Clinical Web Archive

Sign in Subscribe

Berk Toy

Berk Toy

Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial.

This data necessitates careful consideration of donanemab's clinical meaningfulness in early symptomatic Alzheimer disease, particularly regarding its modest effect on functional decline. 💡 Clinical Impact * Mechanistic Why: Donanemab targets and clears deposited amyloid plaques, a pathological hallmark of AD, demonstrating a direct biological intervention. * Clinical/Systemic Benefit: While demonstrating

Crush injury syndrome in earthquakes: a systematic review and meta-analysis on its frequency and complications.

Quick Take: This systematic review and meta-analysis quantifies the substantial morbidity associated with crush injury syndrome in earthquake victims, directly impacting resource allocation and preparedness. 💡 Clinical Impact * Mechanistic Why: Prolonged skeletal muscle ischemia and subsequent reperfusion injury trigger a systemic inflammatory cascade and release of myoglobin, leading to acute kidney

rTMS Modulates Static and Dynamic Brain Functional Networks in Children with Autism Spectrum Disorder: An EEG Microstate Study.

Quick Take: rTMS shows a modulatory effect on brain functional networks in children with ASD, suggesting a potential therapeutic avenue requiring further validation. 💡 Clinical Impact * Mechanistic Why: This data necessitates understanding how rTMS impacts the dynamic and static functional connectivity within the autistic brain, particularly targeting network abnormalities implicated in

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.

Quick Take: Ovarian ablation or suppression significantly reduces breast cancer recurrence and improves survival, particularly in premenopausal women with hormone-sensitive disease. 💡 Clinical Impact * Mechanistic: Ovarian ablation/suppression directly lowers circulating estrogen levels, a critical driver for the growth of ER-positive breast cancers. * Clinical/Systemic: This intervention offers a robust, non-chemotherapy-based

The Efficacy and Toxicity of CNS Prophylaxis in Diffuse Large B-Cell Lymphoma (CLSG-CNS-01): A Randomized, Multicenter, Prospective Phase 3 Trial.

This Phase III RCT robustly demonstrates improved CNS relapse-free survival with high-dose cytarabine consolidation in DLBCL, albeit with increased neurotoxicity. 💡 Clinical Impact * Mechanistic: High-dose cytarabine achieves superior cerebrospinal fluid penetration compared to standard intrathecal prophylaxis, effectively eradicating microscopic leptomeningeal disease. * Clinical/Systemic: This data necessitates a re-evaluation of current CNS

CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials.

CDK4/6 inhibitors with endocrine therapy unequivocally improve progression-free survival in HR+/HER2- advanced breast cancer. 💡 Clinical Impact * Mechanistic: This data solidifies the role of dual pathway inhibition (estrogen receptor and cell cycle progression) in overcoming endocrine resistance, a common obstacle in advanced disease. * Clinical/Systemic: Widespread adoption necessitates updated

Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial.

mRNA-1345 RSV Vaccine + High-Dose Flu Vaccine in Older Adults: Coadministration Efficacy & Safety Quick Take: Coadministration of mRNA-1345 RSV vaccine with a high-dose quadrivalent influenza vaccine in adults 65+ demonstrates non-inferior immunogenicity for both vaccines and an acceptable safety profile, suggesting a viable strategy for combined administration. 💡 Clinical Impact * Mechanistic